On May 17, 2023, ProQR Therapeutics N.V. held its 2023 annual general meeting of shareholders. ProQR shareholders approved the appointment of Theresa Heggie and Begoña Carreño as Supervisory Board member.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.935 USD | +1.31% | -3.78% | -2.81% |
May. 09 | Transcript : ProQR Therapeutics N.V. - Special Call | |
May. 09 | ProQR Therapeutics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.81% | 155M | |
+7.15% | 113B | |
+11.09% | 106B | |
+0.70% | 22.27B | |
-12.30% | 22.22B | |
-5.61% | 19.43B | |
-37.85% | 17.87B | |
-6.04% | 17.24B | |
+7.87% | 14.29B | |
+34.95% | 12.52B |
- Stock Market
- Equities
- PRQR Stock
- News ProQR Therapeutics N.V.
- ProQR Therapeutics N.V. Approves the Appointment of Theresa Heggie and Begoña Carreño as Supervisory Board Member